WO2013065499A1 - 核酸増幅法、核酸基板、核酸分析方法及び核酸分析装置 - Google Patents
核酸増幅法、核酸基板、核酸分析方法及び核酸分析装置 Download PDFInfo
- Publication number
- WO2013065499A1 WO2013065499A1 PCT/JP2012/077024 JP2012077024W WO2013065499A1 WO 2013065499 A1 WO2013065499 A1 WO 2013065499A1 JP 2012077024 W JP2012077024 W JP 2012077024W WO 2013065499 A1 WO2013065499 A1 WO 2013065499A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- amplification method
- reaction
- substrate
- region
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
Definitions
- the present invention relates to a nucleic acid amplification method, a nucleic acid substrate, and a nucleic acid analyzer used for nucleic acid base sequence analysis.
- New technologies for determining the base sequences of DNA and RNA have been developed.
- a method using electrophoresis has been used to determine a base sequence.
- a cDNA fragment sample synthesized by performing a reverse transcription reaction from a DNA fragment or RNA sample for sequencing in advance is prepared, and a known Sanger method is used. After the dideoxy reaction, electrophoresis was performed, and molecular weight separation development patterns were measured and analyzed.
- Non-Patent Document 1 a cluster of amplified gene fragments is formed on a substrate by performing a PCR reaction on the substrate using a primer fixed on the substrate.
- Non-Patent Document 2 emulsion PCR is performed to amplify and fix the nucleic acid sequence on the surface of the fine particles, the fine particles are fixed on the substrate, and a plurality of samples are arranged on a plane.
- cluster formation is an important step, and forming clusters at high density increases the number of amplified gene fragments per cluster by increasing the amount of sequence information that can be acquired from the image sensor at one time. This increases the signal strength of the sequence information, increases the reliability of the sequence information, and at the same time simplifies the detection apparatus.
- a conventional method for producing a large number of clusters by amplification reaction on a substrate is as follows. For example, as disclosed in Patent Document 1, sample DNA as a template is randomly distributed on a substrate and fixed on the substrate in advance. The amplification reaction was performed using the placed primer as a reaction starting point. In this method of randomly distributing the template DNA, when trying to increase the cluster density, the frequency distribution with respect to the number of molecules of the template DNA supplied to a section of a certain area becomes a Poisson distribution. There was a limit that the section supplied with only one molecule would be about 37% at the maximum.
- a cluster density of 4 million / mm 2 should ideally be obtained.
- the sample DNA as a template is immobilized at a high concentration, the template DNA is immobilized on the substrate in close proximity, so that multiple types of DNA are amplified in the same compartment, making correct base sequence analysis impossible.
- the sample DNA is fixed at a low concentration, there remains a problem that the cluster density is lowered and the throughput is lowered.
- Patent Document 2 Also disclosed in Patent Document 2 is a method in which after the amplification reaction is performed, the amplification product is fixed on a fixing pad formed in advance on a substrate.
- the amplification reaction is a rolling cycle amplification (RCA) reaction, and it has been difficult to achieve a high amplification factor exceeding 10,000 times.
- RCA rolling cycle amplification
- fluorescent bright spots must be detected at a high speed, and the number of DNA fragments per cluster is preferably high, but 10,000 by a RCA reaction alone with a practical reaction time of several hours. Achieving a high amplification factor exceeding the double is difficult in terms of DNA synthesis reaction rate.
- the present invention provides a method for amplifying the number of DNA fragments in each cluster to 10,000 molecules or more that can be easily detected while realizing a cluster density higher than expected from the Poisson distribution ratio.
- the inventors of the present invention have developed an amplification method that achieves both a higher density than the cluster density required from the Poisson distribution and a high amplification factor of 10,000 or more DNA fragments in the cluster. did.
- the cluster density is higher than 1.3 million / mm 2 obtained from the Poisson distribution, and the number of DNA fragments in the cluster is amplified to 10,000 molecules or more.
- a nucleic acid amplification method was developed.
- a region where the primer is fixed at a high density on the substrate is isolated and provided at a high density, and the template DNA to be amplified is supplied to the region one molecule at a time.
- a method of supplying molecules one by one it is possible to supply one molecule of template DNA to each fixed region by supplying the template DNA as a molecule having the same or larger physical size than the fixed region. More specifically, for example, a single molecule supply is realized by synthesizing macromolecules of each template DNA by RCA reaction and supplying them to each fixed region to which the primer DNA is fixed.
- an amplification product based on the primer is fixed on the substrate in the primer fixing region by an amplification reaction such as a PCR reaction.
- the RCA reaction product is a macromolecule, since it contains only one type of template DNA as a base sequence, only one type of amplification product is synthesized in each primer fixing region. Therefore, an amplification product substrate that can be sufficiently applied to the subsequent sequence reaction can be produced.
- a cluster density higher than expected from the Poisson distribution ratio which cannot be realized by a conventional method of randomly fixing a sample DNA on a substrate, is realized, and the number of DNA fragments in each cluster is 10,000.
- High-throughput sequence analysis can be realized by increasing the number of DNA fragments per field of view and increasing the number of DNA fragments per field of view and reducing the exposure time required for detection.
- a step of arranging a region where the first nucleic acid is immobilized on the surface of the substrate and a region where the first nucleic acid is not immobilized, and at least two or more base sequences to be analyzed are provided on the same strand.
- a nucleic acid amplification method characterized by comprising a step.
- the average value of the diameter of the second nucleic acid is larger than 1 ⁇ 2 of the average value of the diameter of the region where the first nucleic acid is immobilized.
- the Examples disclose a nucleic acid amplification method characterized in that, in the nucleic acid amplification method, the second nucleic acid is single-stranded and has a self-annealing structure.
- the Examples disclose a nucleic acid amplification method characterized in that the nucleic acid amplification method includes a step of removing the complementary strand of the extension reaction product of the first nucleic acid after the amplification reaction.
- the second nucleic acid is a strand displacement extension reaction product by a polymerase having strand displacement activity using a circular nucleic acid having a base sequence to be analyzed as a template.
- a nucleic acid amplification method is disclosed.
- a nucleic acid amplification method in which, in the nucleic acid amplification method, the amplification reaction is a constant temperature reaction.
- the average value of the diameter of the region where the nucleic acid is immobilized is 500 nm or less, and the nucleic acid is immobilized.
- a nucleic acid substrate characterized in that the average number of molecules of nucleic acid in the region is 10,000 or more.
- a nucleic acid substrate having at least one channel for performing the nucleic acid amplification method is disclosed.
- a nucleic acid analyzer having at least one temperature control device and a liquid feeding mechanism for performing the nucleic acid amplification method is disclosed.
- a bulky DNA molecule 102 is synthesized based on the sample DNA 101 (1). It is necessary that individual bulky DNA molecules 102 hold the base sequence information of the sample DNA 101 on which they are based without being confused.
- a rolling circle amplification (RCA) reaction can be used as a synthesis method therefor. Details thereof are disclosed in Example 3.
- a primer DNA 104 is fixed in a pattern on the surface of the substrate 103. An example of the method for fixing the primer DNA 104 in a pattern is disclosed in Example 2.
- the bulky DNA molecule 102 is fixed to the region where the primer DNA 104 is fixed by hybridization (2).
- the primer DNA 104 has a complementary sequence to the base sequence of a part of the bulky DNA molecule 102.
- the primer DNA 104 may have the same base sequence in each fixed region, and the bulky DNA molecule 102 may have a common base sequence so as to have a complementary sequence thereto.
- the substrate is immersed in an aqueous solution containing a DNA synthase and four types of base substrates, and a primer DNA 104 is subjected to an extension reaction using the bulky DNA molecule 102 as a template to perform double-stranded synthesis (3).
- the complementary strand synthesis reaction (3) using the bulky DNA molecule 102 as a template can be completed by reacting at a constant temperature of about 37 ° C. for about 10 minutes, depending on the type of polymerase used.
- a primer DNA 105 having a direction opposite to that of the primer DNA 104 is provided, and a PCR reaction is performed (4). In this case, if the deenergization is performed at a normal temperature of about 95 ° C.
- the PCR reaction is performed at a constant temperature, and when the double strands are partially separated, the primer DNA 104 anneals and a complementary strand synthesis reaction occurs.
- the factors governing amplification efficiency are the reaction temperature and the concentration of the primer.
- the reaction temperature is preferably between 50 ° C. and 70 ° C., more preferably about 60 ° C.
- the relationship between the density of the primer DNA 104 and the amplification rate was studied earnestly. As a result, it was found that without a fixed density of about 50,000 molecules / ⁇ m 2 ( ⁇ 1 molecule / 4.5 nm square), even if the reaction was carried out for about 3 hours, the amplification factor did not reach 10,000 times. .
- the fixed density of the primer DNA 104 is preferably 10,000 molecules / ⁇ m 2 or more, more preferably 100,000 molecules / ⁇ m 2 or more. With respect to the concentration of the primer DNA 105, sufficient amplification was obtained at about 0.1 to 0.5 ⁇ M, which is the same as the PCR reaction in a normal solution.
- the polymerase an enzyme having strand displacement activity is preferable, and Phi29, Bst polymerase, Csa polymerase, 96-7 polymerase, and the like can be used. After the PCR reaction, a double strand of the extension reaction product of the primer DNA 104 and the extension reaction product of the primer DNA 105 fixed in advance on the substrate 103 is produced on the substrate 103.
- extension reaction product of the primer DNA 105 is removed to form a single strand. It is preferable to keep it.
- the removal method is most convenient and preferably a high temperature treatment, and a single strand sufficient for the sequence reaction can be carried out by treating at 70 ° C. or higher, more preferably 90 ° C. or higher for about 2 minutes.
- the cluster density that is, the fixed region density depends on the fixed region density of the primer DNA 104, and is not restricted by the Poisson distribution.
- One sample DNA 101 can be supplied at a time. For example, if a fixed region is formed with a diameter of 500 nm, a high cluster density of 2 million / mm 2 or more can be achieved.
- the density of DNA in the cluster is determined depending on the amplification factor and the area per cluster. For example, if the primer DNA density is 50,000 molecules / ⁇ m 2 or more in a fixed region (cluster formation region) having a diameter of 500 nm, the amplification factor reaches about 10,000 times in a reaction time of about 3 hours. 10,000 molecules / cluster can be achieved.
- An electron beam positive resist 202 is coated on a smooth support substrate 201 by a spin coating method.
- a smooth support substrate a glass substrate, a sapphire substrate, a silicon wafer or the like is used.
- a quartz substrate or a sapphire substrate having excellent light transmittance may be used.
- the positive resist for electron beam include polymethyl methacrylate and ZEP-520A (manufactured by Nippon Zeon Co., Ltd.). After aligning using the position of the marker on the substrate, electron beam direct drawing exposure is performed to form a through hole in the resist.
- a through hole having a diameter of 200 nm is formed.
- Through-holes depend on the number of nucleic acid molecules that can be analyzed by parallel processing, but forming at a pitch of about 0.5 ⁇ m takes into account the simplicity of manufacturing, high yield, and the number of nucleic acid molecules that can be analyzed by parallel processing. Then it is suitable.
- the through-hole formation region also depends greatly on the position accuracy and position resolution on the detection device side, depending on the number of nucleic acid molecules that can be analyzed by parallel processing. For example, when the primer DNA fixing region is formed at a pitch of 0.5 ⁇ m, 4 million clusters can be formed per 1 mm square.
- a material constituting the bonding pad 203 for example, gold is formed by sputtering.
- a glass substrate or sapphire substrate is used as a smooth support base and gold is used as a bonding pad material
- a thin film of titanium or chromium is used to reinforce the bonding between the substrate material and the bonding pad material. It is preferable to add.
- non-specific adsorption prevention treatment is performed on the surface of the smooth substrate other than that on which the bonding pads 203 are formed.
- coat with molecules having negatively charged functional groups For example, epoxy silane is applied to the surface by spin coating, and after heat treatment, it is treated with a weakly acidic solution (pH 5 to pH 6) to open the epoxy group and introduce OH group to the surface. Adsorption prevention effect can be brought about.
- a thiol group can be used as the functional group 204.
- the substrate provided with the bonding pad 203 is dipped in an aqueous solution of primer DNA 205 having a functional group 204, taken out after a predetermined reaction time, washed with excess aqueous solution, and dried to form the primer DNA in a pattern.
- An immobilized nucleic acid substrate can be prepared. In this embodiment, an example using an electron beam exposure apparatus has been shown, but a nucleic acid substrate can be similarly produced by using an optical exposure apparatus in exactly the same procedure.
- a bonding pad can be provided in a pattern shape using a technique such as nanoimprinting or contact printing.
- a micro phase separation structure is made using a block copolymer in which polymers with different compatibility are connected, and one polymer phase is dissolved to create a concave pattern, which is used as a mold to form a metal pad pattern. Can also be made.
- Sample DNA 301 is fragmented by conventional means such as enzymatic digestion, shearing, or ultrasonic treatment (1).
- the base length of the fragment 302 is preferably between 50 bases and 2000 bases, and more preferably between 100 bases and 500 bases.
- the DNA is combined with the linker DNA to form a circular DNA, and then a DNA synthesis reaction is performed. Therefore, if the fragment is too long, the structure of the bulky DNA may deviate from the desired shape. On the other hand, if it is too short, there is a risk that the amplification factor does not reach a desired value during the amplification reaction on the substrate.
- the fragment length is preferably determined in consideration of the above matters, and it is preferable to select the fragmentation (1) method so that a fragment of that length can be obtained.
- both ends of the fragment 302 It is preferable to smoothen both ends of the fragment 302 and then ligate the adapter 303 to both ends (2).
- a method of filling all overhang 5 ′ single strands with polymerase and dNTPs, or a method of removing 3 ′ overhangs with a polymerase having 3 ′ exonuclease activity can be used.
- circular DNA 305 can be easily synthesized by joining with linker 304 for circularization (3).
- Plasmid DNA can be used for the linker 304 for circularization.
- a multicloning site of plasmid DNA is cleaved with an appropriate restriction enzyme, and a fragment 302 with an adapter 303 is incorporated.
- the integrated plasmid can also be amplified by transformation of E. coli.
- the primer DNA 306 is hybridized to the circular DNA 305 (4), and an RCA reaction is performed using a polymerase having strand displacement activity (5).
- Examples of the polymerase that can be used for the RCA reaction include phi29 polymerase, Bst polymerase, Csa polymerase, and 96-7 polymerase. These polymerases are different in the optimum reaction temperature and conditions, and can be appropriately selected according to the Tm value of the primer sequence to be hybridized. In order to control the size of the RCA product 307, it is necessary to control the reaction time and temperature and to select a polymerase. Furthermore, in the linker 304 for making the ring, for example, as disclosed in Non-Patent Document 3, a base sequence that takes a self-loop structure is placed, so that the RCA product 307 has a spherical shape. Can be controlled to take.
- Non-Patent Document 3 discloses the synthesis of spherical DNA having a diameter of 50 to 150 nm.
- the inventors have obtained an RCA product having a diameter of 100 to 200 nm by incorporating an aptamer structure having a length of 10 to 20 bases into a plasmid DNA having a length of 500 bases and reacting with Csa polymerase for 3 hours.
- the thiol-end modified oligo DNA was immobilized as a primer on a gold pad substrate having a diameter of 100 nm and a pitch between pads of 0.5 ⁇ m formed on a quartz substrate by using the electron beam lithography method described in Example 2.
- Complementary strand synthesis based on the primer by placing the gold pad substrate in a reaction solution containing a predetermined amount of the RCA product, Csa polymerase, reverse primer, and dNTPs and first incubating at 37 ° C. for 10 minutes. Then, the temperature was raised to 60 ° C. and an amplification reaction was performed for 3 hours. After removing unreacted substances by washing, a fluorescent probe DNA having a complementary strand sequence of the synthesized DNA and labeled with Cy3 at the end was hybridized and observed with a fluorescence microscope. Was confirmed to be synthesized. The percentage of gold pads in which amplification products were confirmed was approximately 70%.
- the nucleic acid analyzer of the present example is a bulky template DNA aqueous solution, washing solution, nucleic acid synthase solution, fluorescently labeled substrate (dNTP) for a nucleic acid substrate having a large number of isolated nucleic acid immobilization microregions formed on the surface.
- the reaction chamber is formed by placing the nucleic acid substrate 401 on the temperature control plate 403 and bonding the flow path forming member 402 provided with the flow paths 404 thereon.
- PDMS Polydimethylsiloxane
- a liquid feeding unit 405 is connected to the injection port 714, and all the chemicals necessary for reaction and cleaning are stored in the liquid feeding unit 405.
- a bulky template DNA aqueous solution, a nucleic acid synthesis substrate (dNTP) solution, a reverse primer solution, and a nucleic acid synthase solution are sequentially supplied from the liquid feeding unit 405 to the inlet 714, It is supplied via the flow path 404.
- the temperature of the temperature control plate 403 is raised to 37 ° C., the temperature is kept constant for a predetermined time, and complementary strand synthesis is performed using the primer fixed to the substrate as a starting point.
- the holding time is preferably about 3 to 10 minutes.
- a DNA amplification reaction is performed.
- the reaction time is preferably about 2 to 7 hours.
- a washing solution for washing and removing the unreacted product and the complementary strand of the extension reaction product based on the primer is supplied from the solution feeding unit 405 via the inlet 714 and the channel 404. .
- a sequence reaction is performed, and a single base extension reaction and fluorescence detection are repeated.
- a sequence reaction for example, in the case of a sequential reaction system, a 3′-O-allyl group is protected at the 3′OH position of ribose as a nucleotide with a fluorescent dye as disclosed in Non-Patent Document 4.
- those linked to a fluorescent dye via an allyl group at the 5-position of pyrimidine or at the 7-position of purine can be used. Since the allyl group is cleaved by light irradiation (for example, a wavelength of 355 nm) or contact with palladium, the quenching of the dye and the control of the extension reaction can be simultaneously achieved.
- Fluorescence measurement is performed as follows.
- the light source 407 it is preferable to use a xenon lamp from the viewpoint of necessity of exciting various kinds of phosphors and economical efficiency.
- the optical filter 713 cuts near-ultraviolet light that is unnecessary for excitation and damages the fluorescent dye, and guides it to the objective lens 406 by the dichroic mirror 409, and the nucleic acid substrate 401 is irradiated.
- the dichroic mirror 409 has four types of mirrors having wavelength characteristics suitable for each fluorescent dye. The wavelength to be measured (fluorescent dye) can be switched by holding them on a rotary mirror holder and rotating them at an appropriate angle.
- a nucleic acid analyzer As described above, by assembling a nucleic acid analyzer with a liquid feeding unit, a temperature control plate, an excitation light source, and a fluorescence detection unit, it is possible to automatically perform from the amplification reaction on the sample DNA substrate to the sequence reaction / measurement. As a result, the throughput can be greatly improved over the prior art.
- Fluorescent beads with known number of fluorescent molecules contained in the number of DNA molecules per cluster determined from the performance of the detection device of the present invention (Invitrogen Fluorosphere beads, diameter 200 nm, fluorescent molecules 1.1 ⁇ 10 5 ), the number of fluorescent molecules necessary for detection at a signal to noise ratio of 10 or more was determined. As a result, it was found that 1 ⁇ 10 4 molecules or more are necessary. Therefore, in order to detect a sequence reaction with a signal-to-noise ratio of 10 or more, it is required that at least 10,000 molecules exist per cluster, and an amplification factor of 10,000 times or more is preferable in terms of amplification factor. I understood.
- the number of DNA fragments per cluster can be 10,000 molecules. Therefore, the sequence reaction can be detected with a signal to noise ratio of 10 or more. It was confirmed that it was possible to do.
- nucleic acid analysis method using the nucleic acid amplification method of the present invention will be described with reference to FIG.
- a method for accurately determining the abundance ratio between an abnormal sequence fragment having a mutation at a specific position and a normal sequence fragment having no mutation is disclosed.
- fragmented sample DNA can be fixed and amplified one by one at different positions on the substrate. Therefore, mutations at specific locations contained therein are detected, and the abundance ratio is determined. It can be easily analyzed.
- a bundle (cluster) 502 of nucleic acid sample fragments to be analyzed is formed on a smooth substrate 501.
- a primer 503 having a base sequence up to the position adjacent to the position of the mutation to be detected is supplied to the bundle 502 of nucleic acid sample fragments to perform hybridization.
- the primer 503 is modified with a fluorescent dye 505 at its end.
- an elongation reaction is performed by adding a DNA synthase.
- dideoxyguanine (ddG) is incorporated into the normal sequence to stop the extension reaction
- dideoxyadenine (ddA) is incorporated into the mutant sequence to stop the extension reaction.
- dideoxyguanine is labeled with Cy3
- dideoxyadenine is labeled with Cy5.
- fluorescence is observed by irradiating the smooth substrate 501 with excitation light using a normal fluorescence microscope. Whether or not the fragment includes a base sequence to be analyzed can be determined from the presence or absence of the fluorescent dye 505.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
102 嵩高いDNA分子
103 基体
104、205 プライマDNA
105 逆方向のプライマDNA
106 伸長反応産物
201 支持基体
202 電子線用ポジ型レジスト
203 接着用パッド
204 官能基
206 非特異吸着防止膜
302 フラグメント
303 アダプター
304 環状にするためのリンカー
305 環状DNA
306 プライマDNA
307 RCA産物
401 核酸基板
402 流路形成部材
403 温調プレート
404 流路
405 送液ユニット
406 対物レンズ
407 光源
408 コリメータレンズ
409 ダイクロイックミラー
410、413 光学フィルタ
411 結像レンズ
412 2次元CCDカメラ
Claims (16)
- 基体の表面に第一の核酸を固定した領域と前記第一の核酸を固定していない領域を配置する工程と、解析対象となる塩基配列を少なくとも2つ以上同一鎖上に有する第二の核酸を前記第一の核酸を固定した領域上に固定する工程と、前記第二の核酸の増幅反応を行う工程を含むことを特徴とする、核酸増幅法。
- 基体の表面に第一の核酸を固定した領域と前記第一の核酸を固定していない領域を配置する工程と、解析対象となる塩基配列を少なくとも2つ以上同一鎖上に有する第二の核酸を前記第一の核酸を固定した領域上に固定する工程と、第三の核酸を供給し、前記第一及び第三の核酸をプライマとして前記第二の核酸の増幅反応を行う工程を含むことを特徴とする、核酸増幅法。
- 請求項1に記載の核酸増幅法において、
第一の核酸を固定した領域の直径の平均値の1/2よりも、第二の核酸の直径の平均値が大きいことを特徴とする、核酸増幅法。 - 請求項1に記載の核酸増幅法において、
第二の核酸が一本鎖であり、かつ、自己アニール構造を有することを特徴とする、核酸増幅法。 - 請求項1に記載の核酸増幅法において、
増幅反応後に、第一の核酸の伸長反応産物の相補鎖を除去する工程を含むことを特徴とする、核酸増幅法。 - 請求項1に記載の核酸増幅法において、
第二の核酸が、解析対象の塩基配列を有する環状核酸を鋳型とした、鎖置換活性を有するポリメラーゼによる鎖置換伸長反応産物であることを特徴とする、核酸増幅法。 - 請求項1に記載の核酸増幅法において、
前記増幅反応が恒温反応であることを特徴とする、核酸増幅法。 - 請求項1に記載の核酸増幅法において、
前記第一の核酸が固定された領域の直径の平均値が500nm以下であり、かつ、各固定領域における前記第一の核酸の分子数の平均値が10,000分子以上であることを特徴とする、核酸増幅法。 - 請求項1に記載の核酸増幅法において、
前記第一の核酸が固定されたそれぞれの領域における、前記第一の核酸の固定密度は10,000分子/μm2以上であることを特徴とする、核酸増幅法。 - 請求項9に記載の核酸増幅法において、
前記固定密度は、100,000分子/μm2以上であることを特徴とする、核酸増幅法。 - 請求項1に記載の核酸増幅法において、
前記増幅反応の反応温度が50℃~70℃の間の温度であることを特徴とする、核酸増幅法。 - 請求項1に記載の核酸増幅法において、
前記第二の核酸は、ローリングサイクルアンプリフィケーション(RCA)反応を用いて合成した、嵩高い核酸であることを特徴とする、核酸増幅法。 - 請求項1~12のいずれかに記載の核酸増幅法を行った上で、蛍光標識付き塩基を取り込ませる伸長反応を行う手段と、前記蛍光標識の蛍光検出を行う手段を有することを特徴とする核酸分析方法。
- 解析対象となる塩基配列を含む核酸が基体上に固定された核酸基板において、前記核酸が固定された領域の直径の平均値が500nm以下であり、かつ、前記核酸の固定領域における核酸の分子数の平均値が10,000分子以上であることを特徴とする、核酸基板。
- 請求項1に記載の核酸増幅法を行うための、少なくとも1つ以上の流路を有する核酸基板。
- 請求項1に記載の核酸増幅法を行うための、少なくとも一つの温調装置と送液機構を有する核酸分析装置。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12846413.8A EP2774978B1 (en) | 2011-10-31 | 2012-10-19 | Nucleic acid amplification method |
US14/346,342 US9708649B2 (en) | 2011-10-31 | 2012-10-19 | Method and substrate for nucleic acid amplification, and method and apparatus for nucleic acid analysis |
CN201280052238.8A CN103890161A (zh) | 2011-10-31 | 2012-10-19 | 核酸扩增方法、核酸基板、核酸分析方法及核酸分析装置 |
JP2013541701A JP5899234B2 (ja) | 2011-10-31 | 2012-10-19 | 核酸増幅法、核酸基板、核酸分析方法及び核酸分析装置 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011238156 | 2011-10-31 | ||
JP2011-238156 | 2011-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013065499A1 true WO2013065499A1 (ja) | 2013-05-10 |
Family
ID=48191854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2012/077024 WO2013065499A1 (ja) | 2011-10-31 | 2012-10-19 | 核酸増幅法、核酸基板、核酸分析方法及び核酸分析装置 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9708649B2 (ja) |
EP (1) | EP2774978B1 (ja) |
JP (1) | JP5899234B2 (ja) |
CN (1) | CN103890161A (ja) |
WO (1) | WO2013065499A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013094067A (ja) * | 2011-10-28 | 2013-05-20 | Hitachi High-Technologies Corp | 核酸増幅方法 |
JP2015116136A (ja) * | 2013-12-17 | 2015-06-25 | 東ソー株式会社 | 核酸増幅方法および当該方法を利用した核酸増幅試薬 |
JP2015139373A (ja) * | 2014-01-27 | 2015-08-03 | 株式会社日立ハイテクノロジーズ | 生体分子分析デバイス、及び生体分子分析装置 |
WO2019207669A1 (ja) * | 2018-04-25 | 2019-10-31 | 株式会社 日立ハイテクノロジーズ | 核酸分析用基板、及び核酸分析用フローセル |
JP7499767B2 (ja) | 2018-12-07 | 2024-06-14 | エレメント バイオサイエンシーズ,インク. | フローセルデバイスおよびその使用 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111172247A (zh) * | 2020-01-15 | 2020-05-19 | 深圳海普洛斯医学检验实验室 | 一种高通量测序文库定量检测结果校正的方法及检测方法 |
US11535892B1 (en) | 2021-06-17 | 2022-12-27 | Element Biosciences, Inc. | Compositions and methods for pairwise sequencing |
US11859241B2 (en) | 2021-06-17 | 2024-01-02 | Element Biosciences, Inc. | Compositions and methods for pairwise sequencing |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002525125A (ja) | 1998-09-30 | 2002-08-13 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | 核酸増幅および配列決定の方法 |
JP2009500004A (ja) * | 2005-06-15 | 2009-01-08 | カリダ・ジェノミックス・インコーポレイテッド | 遺伝子解析および化学解析用の単分子アレイ |
JP2011520420A (ja) | 2007-12-05 | 2011-07-21 | コンプリート・ジェノミックス・インコーポレイテッド | シーケンシング反応における効率のよい塩基決定 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6284497B1 (en) * | 1998-04-09 | 2001-09-04 | Trustees Of Boston University | Nucleic acid arrays and methods of synthesis |
EP1522853A4 (en) | 2002-06-24 | 2005-10-19 | Canon Kk | DNA MICROARRAY WITH STANDARD PROBE AND KIT CONTAINING THE MICROARRAY |
GB2413796B (en) * | 2004-03-25 | 2006-03-29 | Global Genomics Ab | Methods and means for nucleic acid sequencing |
WO2007120208A2 (en) * | 2005-11-14 | 2007-10-25 | President And Fellows Of Harvard College | Nanogrid rolling circle dna sequencing |
JP5299986B2 (ja) | 2007-11-01 | 2013-09-25 | 国立大学法人山口大学 | 核酸の定量方法 |
WO2010043418A2 (de) * | 2008-10-17 | 2010-04-22 | Febit Holding Gmbh | Integrierte amplifikation, prozessierung und analyse von biomolekülen in einem mikrofluidischen reaktionsträger |
EP2182075A1 (en) * | 2008-10-20 | 2010-05-05 | Koninklijke Philips Electronics N.V. | Real-time high multiplex detection by primer extension on solid surfaces |
-
2012
- 2012-10-19 JP JP2013541701A patent/JP5899234B2/ja not_active Expired - Fee Related
- 2012-10-19 US US14/346,342 patent/US9708649B2/en active Active
- 2012-10-19 WO PCT/JP2012/077024 patent/WO2013065499A1/ja active Application Filing
- 2012-10-19 CN CN201280052238.8A patent/CN103890161A/zh active Pending
- 2012-10-19 EP EP12846413.8A patent/EP2774978B1/en not_active Not-in-force
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002525125A (ja) | 1998-09-30 | 2002-08-13 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | 核酸増幅および配列決定の方法 |
JP2009500004A (ja) * | 2005-06-15 | 2009-01-08 | カリダ・ジェノミックス・インコーポレイテッド | 遺伝子解析および化学解析用の単分子アレイ |
JP2011520420A (ja) | 2007-12-05 | 2011-07-21 | コンプリート・ジェノミックス・インコーポレイテッド | シーケンシング反応における効率のよい塩基決定 |
Non-Patent Citations (6)
Title |
---|
ANDERSON JP. ET AL.: "Fluorescent structural DNA nanoballs functionalized with phosphate-linked nucleotide triphosphates", NANO LETT., vol. 10, no. 3, 2010, pages 788 - 792, XP055117086 * |
NANO LETTER, vol. 10, 2010, pages 788 - 792 |
NUCLEIC ACIDS RESEARCH, vol. 28, no. 20, 2000, pages E87 |
P. N. A. S., vol. 103, 2006, pages 19635 - 19640 |
SCIENCE, vol. 309, 2005, pages 1728 - 1732 |
See also references of EP2774978A4 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013094067A (ja) * | 2011-10-28 | 2013-05-20 | Hitachi High-Technologies Corp | 核酸増幅方法 |
JP2015116136A (ja) * | 2013-12-17 | 2015-06-25 | 東ソー株式会社 | 核酸増幅方法および当該方法を利用した核酸増幅試薬 |
JP2015139373A (ja) * | 2014-01-27 | 2015-08-03 | 株式会社日立ハイテクノロジーズ | 生体分子分析デバイス、及び生体分子分析装置 |
WO2019207669A1 (ja) * | 2018-04-25 | 2019-10-31 | 株式会社 日立ハイテクノロジーズ | 核酸分析用基板、及び核酸分析用フローセル |
JP7499767B2 (ja) | 2018-12-07 | 2024-06-14 | エレメント バイオサイエンシーズ,インク. | フローセルデバイスおよびその使用 |
Also Published As
Publication number | Publication date |
---|---|
CN103890161A (zh) | 2014-06-25 |
US9708649B2 (en) | 2017-07-18 |
EP2774978A1 (en) | 2014-09-10 |
EP2774978B1 (en) | 2019-05-15 |
EP2774978A4 (en) | 2015-07-15 |
US20140309120A1 (en) | 2014-10-16 |
JPWO2013065499A1 (ja) | 2015-04-02 |
JP5899234B2 (ja) | 2016-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5899234B2 (ja) | 核酸増幅法、核酸基板、核酸分析方法及び核酸分析装置 | |
JP5260339B2 (ja) | 核酸分析デバイス、及び核酸分析装置 | |
EP3336199B1 (en) | Single molecule sequencing method, device, system, and application | |
US10590481B2 (en) | Cyclic single molecule sequencing process | |
US20050227231A1 (en) | Device for sequencing nucleic acid molecules | |
US20160362741A1 (en) | Single molecule sequencing of captured nucleic acids | |
EP4271510A1 (en) | Methods and compositions for light-controlled surface patterning using a polymer | |
JP5663008B2 (ja) | 核酸分析デバイスの製造方法 | |
US20110092380A1 (en) | Improved molecular-biological processing equipment | |
JP5822929B2 (ja) | 核酸分析装置 | |
JPWO2010137543A1 (ja) | 核酸分析用デバイス、核酸分析装置、及び核酸分析方法 | |
JP5309092B2 (ja) | 核酸分析用デバイス,核酸分析装置、及び核酸分析用デバイスの製造方法 | |
JP6339787B2 (ja) | 核酸の分析方法 | |
JP5635130B2 (ja) | 単分子プローブ核酸付き微粒子及びその製造方法、並びに核酸分析方法 | |
US20240279723A1 (en) | Compositions and methods for in situ single cell analysis using enzymatic nucleic acid extension | |
JP5908252B2 (ja) | 核酸増幅方法 | |
WO2011092780A1 (ja) | 核酸分析装置,核酸分析反応デバイス、および核酸分析用反応デバイス用基板 | |
US20050014147A1 (en) | Method and apparatus for three label microarrays | |
JP2001299346A (ja) | 固定化プライマーによる固相pcr法 | |
WO2011108344A1 (ja) | 基板上に固定化された複数の核酸検体の識別方法及び装置 | |
JP2008151647A (ja) | マイクロアレイ上のプローブ位置の確認方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12846413 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2013541701 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012846413 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14346342 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |